Baron Health Care Fund adds TMO, ARQT, and ELAN; exits Cidara Therapeutics, MASI among Q4 moves
Source: SeekingAlpha
2026-03-06 08:28:08 ET
More on Thermo Fisher Scientific, Arcutis Biotherapeutics, etc.
- Thermo Fisher Scientific Inc. (TMO) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
- Elanco Animal Health Incorporated (ELAN) Presents at TD Cowen 46th Annual Health Care Conference Transcript
- Thermo Fisher Scientific: Recovery In Life Sciences Solutions
- Masimo Q4 2025 Earnings Preview
- Elanco targets $1.15B innovation revenue in 2026 as Big 6 launches gain momentum
Read the full article on Seeking Alpha
For further details see:
Baron Health Care Fund adds TMO, ARQT, and ELAN; exits Cidara Therapeutics, MASI among Q4 moves
Repligen Corporation
NASDAQ: RGEN
RGEN Trading
-4.34% G/L:
$119.02 Last:
432,191 Volume:
$120.66 Open:
RGEN Latest News
RGEN Stock Data
$8,061,398,164
55,615,260
0.31%
211
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham
